ITC

A 2023 Apple Watch import ban made the ITC a focal point for how patent disputes can disrupt major consumer-tech products and spur software workarounds.

Who they are

ITC appears in this coverage as the US trade agency whose patent-infringement decisions can restrict imports, making it a consequential venue for technology companies contesting products from smartwatches and phones to speakers, fitness devices, and GPUs.

The recent arc

Coverage peaked in late 2023 around the ITC’s Masimo-related import ban on Apple Watch Series 9 and Apple Watch Ultra 2. Apple prepared to halt US sales, the Biden administration declined to veto the order, and an appeals court then paused the ban; subsequent reporting followed Apple’s proposed software workaround and its appeal of the decision.

The tension

The recurring tension is that an ITC remedy targets imported products, giving patent holders leverage that can quickly affect mass-market hardware. Apple’s conflict with Masimo is the clearest recent example, while the Google-Sonos ruling, Qualcomm’s iPhone complaint involving Intel components, and Oura’s case against Ultrahuman show the same forum operating across consumer-tech rivalries.

Why it matters

If this pattern continues, the ITC will remain a high-stakes pressure point for companies with globally manufactured products: a finding can force sales changes, litigation appeals, redesigns, or software-based attempts to avoid infringement. The Apple and Ultrahuman episodes also suggest that outcomes can shape product availability, though the durability of any workaround or exclusion depends on later legal and regulatory decisions.

Related: Apple · Apple Watch · Sonos · Qualcomm · A US appeals court pauses the ITC's Apple Watch Series 9 and Ultra 2 i · Apple rolls out a software update that enables a redesigned blood oxyg